Company Overview and News
The company formerly known as the Foy Group appears to have walked away from its plans to build a plastics-to-fuel plant in the ACT, selling its block in Hume the day after it finally settled.
The company formerly known as Foy Group has finally secured the lease over a block of land at Hume for either its controversial plastics-to-fuel plant, another manufacturing plant, or both.
Whoopee! Clover Moore wants a faster train service to Canberra. So do I as a lifelong rail fan. But when will these people face reality? The problem with the Sydney-Canberra train is not the rolling stock or even the infrastructure but the fact that it makes nine stops en route, each of which costs the train five minutes or more. Eliminate them, and you will save an hour. But it is a NSW train and it won't happen.
The plastics-to-fuel plant proponents formerly known as the Foy Group has an extra month to pay the ACT government the millions of dollars it owes on a block of land in Hume.
It's a frosty morning, but we're expecting a sunny day to follow - not bad after all that rain. It dipped only just below freezing overnight, and the weather bureau has forecast a maximum of 15 degrees.
The Canberra director of development company Knight Frank has raised concerns as to how his company's name ended up sending a submission to an inquiry panel supporting the proposed waste plastic to fuel facility in Hume.
An ACT government health panel set up to investigate a plastics to fuel factory at Hume has effectively killed off the plan, warning the facility posed potentially serious fire, explosion and other environmental risks.
Draft terms of reference have been drawn up for the newly appointed expert panel overseeing the independent inquiry into the plastics to fuel facility proposed for Hume.
The Foy Group has pushed back on the need for a formal health impact assessment of planned plastics-to-fuel factory, saying the minimal air emissions from the plant will be well under health limits.
What's not to like about a facility using Australian-patented technology to convert non-recyclable plastic into "road-ready" diesel and petrol with barely registrable noise and odour levels, and with negligible emissions of harmful chemicals? Oh, and which will employ up to 30 people and inject millions of dollars into the ACT economy?
11h - Asif
Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...